Past Virtual Events

Past Discussion Sessions | Past Industry Updates | Upcoming Virtual Events

Click here to access APC's tips and tricks to navigating Zoom!

Past Discussion Sessions

Title: APC SPECIAL TOWN HALL: Intro to Rapid Acceleration of Diagnostics (RADx) Programs (Lab-Based PCR Testing)
Date: Monday, December 14, 2020
Time: 5:00pm ET/ 4:00pm CT/ 3:00pm MT/ 2:00pm PT Duration: 1.5 hours
Sections: Open to all APC/Section members
Event Material: Click here to access the members-only webpage to view and listen to the recording

Event Description: Rapid Acceleration of Diagnostics (RADx) leadership has been in touch with APC about the progress of their initiatives, which are in various states of approval – some more advanced than others. Of the more advanced projects, several have capacity to potentially support academic labs or supplement university testing strategies with PCR diagnostic testing. RADx and APC have arranged to present four in-lab PCR testing options in a Special Town Hall. 

Moderator: Michael L. Talbert, MD, Vice Chair at University of Oklahoma 

Event Description: Many institutions have changed their funds flow, are in the process of such a change, or are contemplating fundamental changes in how dollars and other resources flow through their organizations. The process often first focuses on the clinical operations. Education and research may seem to almost be afterthoughts. For a unique and hybrid specialty like pathology, maintenance and growth of these missions may be compromised by changes in funds flow and what these changes engender. In preparation for this virtual discussion group, view in advance the three recordings of different models presented by Chair/Administrator representatives of institutions that have implemented funds flow models (listed below). The moderator will facilitate a question-and-answer session with the panelists, and then encourage audience discussion and reporting on funds flow issues in their institution, first on education and research, then on clinical operations.

Required viewing of three funds flow examples by the panelists:

• University of California San Diego, Kai Wang, Vice Chair of Administration (8:24)
• University of North Carolina, J. Charles Jennette, MD, Past Chair and Professor (14:40)
• University of Vermont, Debra G.B. Leonard, MD, PhD, Chair and Professor (23:38)

• Ralph Green, MD, PhD, (APC Senior Fellow), University of California, Davis
• Chen Liu, MD, PhD, Chair at Yale University
• David Roth, MD, PhD, Chair at the University of Pennsylvania

Event Description: 

Register for an upcoming APC Town Hall to learn and discuss a variety of experiences in dealing with new CLIA-certified labs on university campuses. The emergence of the COVID-19 pandemic has accelerated and amplified concerns for academic pathology and maintaining best practices in the delivery of health care. Join a panel of pathology chairs to discuss:

• Are “pop-up” CLIA labs in competition with the pathology department?
• Are research operations familiar with CLIA?
• What’s the role of non-CLIA assays in surveillance of a population? How can these assays be harmonized within a campus? Who is doing what type of testing?
• Who has oversight of new CLIA labs? How should concerns with non-pathologists serving as lab directors be addressed?
• How can the academic pathology laboratory offer innovative testing capacity by working with the hospital and the research community on campus? 

Reference to Dr. Green’s paper on “Blueprint for a pop-up SARS-CoV-2 testing lab” (Nature Biotechnology, 2020). 

Featured Speaker:

Vivian Pinn, MD
Senior Scientist Emerita at the NIH, Fogarty International Center
Former Chair, Department of Pathology, Howard University College of Medicine

Event Description:
This 2-hour session will continue and enhance the discussion on diversity and leadership development in pathology departments from the APC 2020 Leadership Development & Diversity Session moderated by Committee Chair, Dani Zander, MD, and featuring Vivian Pinn, MD (Senior Scientist Emerita at the NIH, Fogarty International Center, and former Chair, Department of Pathology, Howard University College of Medicine), with Jiaoti Huang, MD, PhD (Duke University), Jennifer Hunt, MD (University of Florida), Cheryl Hanau, MD (Drexel University) and Amyn Rojiani, MD (Medical College of Georgia at Augusta University). Pre-requisite viewing on Dr. Pinn’s recorded presentation and the panel discussion is essential to pick-up the conversation when you join the discussion session! Open to all APC/Section members.

Title: Effective and Ethical Screening of Residency Applicants
Date: Tuesday, September 1, 2020
Time: 1pm ET / 12pm CT / 11am MT / 10 am PT

Event Description: This 90-minute virtual Discussion Group is co-moderated by Robert Hoffman, MD, PhD (Vanderbilt University Medical Center), and Charles Timmons, MD, PhD (University of Texas Southwestern/Texas Children’s Hospital). Open to all APC/Section members, especially PRODS and GMEAS.
Event Recording: Click here to access the members-only webpage to view and listen to the recording.


Click Here to View Upcoming Discussion Sessions

Past Industry Updates

APC Industry Updates are a new offering promoted to APC membership to keep you up to date on the latest products or services from commercial companies or other organizations. APC does not endorse any products or services in these Industry Updates.

Event Recording: Click here to access Foundation Medicine's industry Update recording

Featured Speaker:

Jeffrey S. Ross, M.D.

Medical Director 

Event Description: 

How comprehensive genomic profiling using both tissue and liquid biopsies is leading to more personalized targeted therapy and immunotherapy for women with clinically advanced and metastatic breast cancer.

Key Learning Objectives: 

• Familiarize the audience with the genomic characteristics of the 3 major types of advanced breast cancer: ER+/HER2-, HER2+ and triple negative
• Compare the results of tissue based and blood-based clinical DNA sequencing in patients with advanced breast cancer
• Demonstrate how new companion diagnostics are driving the use of targeted therapies i.e. the anti-PIK3CA drug alpelisib and immunotherapies i.e. the immune checkpoint inhibitor drug pembrolizumab for cases with tumor mutation burden (TMB) > 10 mutations/Mb.

This virtual event was made possible through sponsorship by Foundation Medicine 

Featured Speakers:

Charlene R Gettings, MS, PA(ASCP), Masters, Pathologists’ Assistant & 
Marissa K Spencer, MS, PA(ASCP), Masters, Pathologists’ Assistant

Event Description: 

This presentation will be a discussion on the knowledge and training of PAs, and how to best utilize them in the training of residents in the gross room and autopsy. As a result of our training, Pathologists’ Assistants are uniquely qualified as experts in gross pathology and autopsy prosecution making them ideal for training and oversight of residents in the gross room, frozen section room, and the autopsy suite - more expertise than a senior resident and more available than an attending pathologist.  Pathologists’ Assistants can cover all elements listed in the ACGME milestones for patient care/grossing. Pathologists’ Assistants can provide all in one training and oversight along with supporting documentation as new residents progress through each specimen type. 

Key Learning Objectives: 

• PA program studies, level of education, and ASCP certification
• Ways to best utilize PAs in training of residents
• Some common gaps in communication/workflow – how to spot them and avoid them

This virtual event was made possible through sponsorship by AAPA

Featured Speaker:

 

David Boissonault, BS in Business Management
Business Development - Digital Pathology, Sectra

Event Description:

Sectra will provide an overview of their digital pathology solution which was recently FDA approved for primary diagnostics. Then, listen in as Dr. Thomas Bauer, Pathologist-in-Chief at Hospital for Special Surgery in New York City describes his journey of implementing the Sectra solution into his day to day operations.

Key Learning Objectives:

• Understand workflow changes and improvements from digital pathology
• Review the necessary components to have in place for a successful implementation
• Learning lessons for implementing a digital pathology solution

This virtual event was made possible through sponsorship by Sectra

Featured Speaker:

Event Description: This Industry Update will demonstrate how laboratories across the United States are easily accessing and managing their laboratory data.  Strategies will be discussed for how you can improve on areas key to the lab and access the critical data you need now, right at your fingertips. This virtual event will cover analytics in areas key to the lab including:

• COVID-19 Reporting
• Turnaround Times
• Test Utilization
• Quality
• QC
• Productivity/Workflow
• Blood Bank
• Anatomic Pathology
• Peer Comparison
• and more

This virtual event was made possible through sponsorship by Visiun

 Using Digital Pathology to Enhance Pathology Education

This webinar was made possible through sponsorship by Philips.

Original broadcast on Thursday, February 21, 2019 at 12:00 pm (ET): Click here to view and listen to the recorded broadcast..

Join Douglas J. Hartman, MD, as he shares his experience of using Philips Pathology Education Tutor. Learn how his team is enhancing their pathology teaching and how they have overcome some of the traditional educational limitations with the help of digital pathology. Tutor is not intended for diagnostic, monitoring or therapeutic purposes or in any other manner for regular medical practice.

Douglas J. Hartman, MD (Speaker)
Associate Professor of Pathology, Division of Anatomic Pathology; Associate Director of the Pathology Informatics Division; Director of the Image Analysis Laboratory

Click Here to View Upcoming Industry Update Webinars